← Back to PressPress ReleaseAlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. PlansNOVEMBER 12, 2025